Jing Zhang

Title: Innovations of Jing Zhang in Thromboembolic Disorder Treatment

Introduction

Jing Zhang is an accomplished inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target thromboembolic disorders. Her innovative work has led to the creation of a patent that holds promise for improving treatment options in this area.

Latest Patents

Jing Zhang holds a patent for "Pyridine N-oxide derivatives useful as factor XIa inhibitors." This invention is directed towards pyridine N-oxide derivatives, stereoisomers, isotopologues, isotopomers, and pharmaceutically acceptable salts thereof. The patent also covers pharmaceutical compositions containing these compounds and their use in the treatment and/or prophylaxis of thromboembolic disorders, inflammatory disorders, and diseases or conditions in which plasma kallikrein activity is implicated.

Career Highlights

Jing Zhang is currently employed at Janssen Pharmaceutica NV, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on addressing critical health issues through pharmaceutical advancements.

Collaborations

Jing collaborates with notable colleagues, including Guozhang Xu and Boying Guo, who contribute to her research endeavors. These collaborations enhance the scope and impact of her work in the pharmaceutical industry.

Conclusion

Jing Zhang's innovative contributions to the field of pharmaceuticals, particularly through her patent on pyridine N-oxide derivatives, highlight her role as a key inventor in the treatment of thromboembolic disorders. Her ongoing work at Janssen Pharmaceutica NV continues to pave the way for advancements in medical treatments.